P. Gilligan

发表

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a

E. Baron, J. Miller, M. Weinstein, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Microbiology of airway disease in patients with cystic fibrosis

P. Gilligan, P H Gilligan, P. H. Gilligan, 1991, Clinical Microbiology Reviews.

A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults

Matthew L. Rubinstein, S. Richter, P. Gilligan, 2019, Clinical Microbiology Reviews.

Clinical Microbiology Laboratories' Adoption of Culture-Independent Diagnostic Tests Is a Threat to Foodborne-Disease Surveillance in the United States

P. Gilligan, K. Kubota, Melissa B. Miller, 2016, Journal of Clinical Microbiology.

Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care.

P. Gilligan, F. Henderson, D. Goff, 1988, The Journal of infectious diseases.

Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic Fibrosis

P. Gilligan, Melissa B. Miller, A. Kerr, 2009, Journal of Clinical Microbiology.

Reflect urine culture cancellation in the emergency department.

Christopher W. Jones, P. Gilligan, Karissa Culbreath, 2014, The Journal of emergency medicine.

Patterns of Epithelial Cell Invasion by Different Species of the Burkholderia cepacia Complex in Well-Differentiated Human Airway Epithelia

P. Gilligan, J. Yankaskas, R. Boucher, 2002, Infection and Immunity.

Clinical outcomes in cystic fibrosis patients with Trichosporon respiratory infection.

P. Gilligan, F. Lin, A. Kerr, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Infections in Patients with Cystic Fibrosis

P. Gilligan, 2014, Clinics in Laboratory Medicine.

Defining antimicrobial resistance in cystic fibrosis.

P. Gilligan, V. Waters, J. Lipuma, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study

P. Gilligan, M. Wolfgang, N. McElvaney, 2018, European Respiratory Journal.

Anaerobic bacteria cultured from CF airways correlate to milder disease-a multisite study

P. Gilligan, M. Wolfgang, N. McElvaney, 2018 .

Relative frequency of Clostridium difficile in patients with diarrheal disease

L. R. Mccarthy, P. Gilligan, L. McCarthy, 1981, Journal of clinical microbiology.

Identification of pathogens by classical clinical tests

P. Gilligan, 2013 .

Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.

L. Saiman, P. Gilligan, V. Waters, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

290 – Mechanisms and Detection of Antimicrobial Resistance

P. Gilligan, Melissa B. Miller, M. Miller, 2012 .

Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility.

P. Gilligan, D. Morrell, A. Ortega‐Loayza, 2010, Journal of the American Academy of Dermatology.

Diarrheal Disease in the Hospitalized Patient

P. Gilligan, 1986, Infection Control.

Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

E. Baron, J. Miller, M. Weinstein, 2013, Clinical Infectious Diseases.

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.

P. Gilligan, P. Noone, D. Esserman, 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Detection of Rapidly Growing Mycobacteria in Routine Cultures of Samples from Patients with Cystic Fibrosis

S. Hoberman, P. Gilligan, J. Fine, 2011, Journal of Clinical Microbiology.

Lung transplant outcomes in cystic fibrosis patients with pre‐operative Mycobacterium abscessus respiratory infections

P. Gilligan, P. Noone, L. Lobo, 2013, Clinical transplantation.

Laboratory Diagnosis of Non-Tuberculous Mycobacterium Infections in Bronchiectasis Patients: Issues and Controversies

P. Gilligan, Kara J. Levinson, 2017 .

Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients.

P. Gilligan, F. Lin, C. Esther, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis

P. Gilligan, M. Knowles, M. Knowles, 1993, Journal of clinical microbiology.

Nontuberculous mycobacteria in adult patients with cystic fibrosis.

P. Gilligan, M. Knowles, J. Yankaskas, 1992, Chest.

“Pathogen Eradication” and “Emerging Pathogens”: Difficult Definitions in Cystic Fibrosis

S. Funk, P. Gilligan, M. Tunney, 2018, Journal of Clinical Microbiology.

Prevalence of Vancomycin-Resistant Enterococcus in Prenatal Screening Cultures

P. Gilligan, Melissa B. Miller, S. Allen, 2004, Journal of Clinical Microbiology.

Towards “Molecular Esperanto” or the Tower of Babel? (The Need for Harmonization of Techniques for Genotyping Clinical Isolates of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis)

P. Gilligan, J. Elborn, J. Moore, 2003, Journal of Clinical Microbiology.

Six-Year Molecular Analysis of Burkholderia cepacia Complex Isolates among Cystic Fibrosis Patients at a Referral Center for Lung Transplantation

P. Gilligan, J. Lipuma, D. Weber, 2002, Journal of Clinical Microbiology.

Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

P. Gilligan, J. Lipuma, R. Aris, 2001, American journal of respiratory and critical care medicine.

Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi.

P. Gilligan, I. Hoffman, C. Vorkas, 2012, Malawi medical journal : the journal of Medical Association of Malawi.

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya

S. Telford, J. Miller, M. Weinstein, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The development of antimicrobials and vaccines against bacterial bioterrorism agents--where are we?

P. Gilligan, 2004, Drug discovery today.

Clostridium difficile testing algorithms: what is practical and feasible?

P. Gilligan, Monica L. Schmidt, 2009, Anaerobe.

Cases in Medical Microbiology and Infectious Diseases

P. Gilligan, D. S. Shapiro, M. Smiley, 1992 .

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

S. Telford, J. Miller, M. Weinstein, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diarrheal disease and DRGs

P. Gilligan, 1986, Clinical Microbiology Newsletter.

Population-level genomics identifies the emergence and global spread of a human transmissible multidrug-resistant nontuberculous mycobacterium

Judith, Terese, L. Morawska, 2016 .

Evaluation of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Samples from Patients with Cystic Fibrosis in the United States

P. Gilligan, J. Perry, R. Plongla, 2017, Journal of Clinical Microbiology.

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya.

S. Telford, J. Miller, M. Weinstein, 2018 .

Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis

P. Gilligan, D. Schidlow, B. Decicco, 1985, Journal of clinical microbiology.

Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis

C. Pai, P. Gilligan, J. Matsen, 1987, Journal of clinical microbiology.

The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome.

P. Gilligan, J. Yankaskas, R. Aris, 1997, American journal of respiratory and critical care medicine.

Bacterial infections in Lilongwe, Malawi: aetiology and antibiotic resistance

P. Gilligan, W. Miller, F. Martinson, 2012, BMC Infectious Diseases.

Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells.

T. Boat, P. Gilligan, P. Cheng, 1993, The American review of respiratory disease.

Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis

P. Gilligan, F. Lin, Melissa B. Miller, 2014, Pediatric pulmonology.

Laboratory Aspects of Management of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

P. Gilligan, Melissa B. Miller, M. Miller, 2003, Journal of Clinical Microbiology.

MINIREVIEW Impact of Clinical Practice Guidelines on the Clinical Microbiology Laboratory

P. Gilligan, 2004 .

Is there value in susceptibility testing of Pseudomonas aeruginosa causing chronic infection in patients with cystic fibrosis?

P. Gilligan, 2006, Expert review of anti-infective therapy.

Lung infection with Burkholderia gladioli in a child with cystic fibrosis: Acute clinical and spirometric deterioration

P. Gilligan, R. Wood, P. Barker, 1997, Pediatric pulmonology.

Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis

P. Gilligan, K. Wait, D. Welch, 1987, Journal of clinical microbiology.

Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania.

P. Gilligan, L. Brown, J. Gajewski, 1985, Pediatrics.

Clostridium difficile cytotoxin in a pediatric population.

P. Gilligan, M. Fisher, S. Long, 1983, American journal of diseases of children.

Differentiation of Clostridium difficile Toxin from Clostridium botulinum Toxin by the Mouse Lethality Test

P. Gilligan, R. Berman, L. Brown, 1983, Applied and environmental microbiology.

Detection of Mycobacterium abscessus from Deep Pharyngeal Swabs in Cystic Fibrosis

P. Gilligan, A. Kerr, C. Esther, 2015, Infection Control & Hospital Epidemiology.

Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study.

P. Gilligan, S. Spinola, C. Sheaffer, 1986, The Journal of pediatrics.

Importance of culture in laboratory diagnosis of Bordetella pertussis infections

P. Gilligan, M. Fisher, 1984, Journal of clinical microbiology.

Contemporary approaches for the laboratory diagnosis of Clostridium difficile infections

P. Gilligan, 2014 .

Point-Counterpoint: What Is the Current Role of Algorithmic Approaches for Diagnosis ofClostridium difficile Infection?

P. Gilligan, F. Fang, M. Wilcox, 2010, Journal of Clinical Microbiology.

CASE STUDIES: Neck Pain and Rash in an 18-Year-Old Student

P. Gilligan, M. Willis, M. Roth, 2005 .

Recovery of resistant enterococci during vancomycin prophylaxis

A. Kaplan, P. Gilligan, R. Facklam, 1988, Journal of clinical microbiology.

Laboratory diagnosis ofClostridium difficileinfection

P. Gilligan, 2013 .

In Vitro Activities of Designed Antimicrobial Peptides against Multidrug-Resistant Cystic Fibrosis Pathogens

P. Gilligan, D. Henke, U. Schwab, 1999, Antimicrobial Agents and Chemotherapy.

Antigenuria after Haemophilus influenzae type b polysaccharide vaccination.

P. Gilligan, S. Spinola, C. Sheaffer, 1986, The Journal of pediatrics.

A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.

M. King, P. Gilligan, M. Knowles, 1990, The New England journal of medicine.

Aortic Valve Insufficiency in a 45-Year-Old Male

P. Gilligan, M. Willis, M. Roth, 2005 .

Point-Counterpoint: Should Interferon Gamma Release Assays Become the Standard Method for Screening Patients for Mycobacterium tuberculosis Infections in the United States?

P. Gilligan, Melissa B. Miller, T. Alexander, 2011, Journal of Clinical Microbiology.

Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

Ashwin N Ananthakrishnan, Lynne V McFarland, A. Ananthakrishnan, 2013, The American Journal of Gastroenterology.

Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study.

M. King, P. Gilligan, M. Knowles, 1991, Advances in experimental medicine and biology.

Pathogen eradication ” and “ Emerging pathogens ” : 3 Difficult definitions in cystic fibrosis 4 5

S. Funk, P. Gilligan, M. Tunney, 2018 .

Evolution of Testing Algorithms at a University Hospital for Detection of Clostridium difficile Infections

P. Gilligan, Karissa Culbreath, A. Kerr, 2012, Journal of Clinical Microbiology.

Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center.

P. Gilligan, M. Knowles, J. Yankaskas, 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Absorption of oral vancomycin - possible associated toxicity.

P. Gilligan, S. Long, J. Prebis, 1983, The International journal of pediatric nephrology.

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

L. Morawska, L. Knibbs, H. Rodgers, 2016, Science.

Emergence of vancomycin resistance in coagulase-negative staphylococci.

P. Gilligan, J. Stapleton, R. Schwalbe, 1987, The New England journal of medicine.

Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections

P. Gilligan, K. Rodino, S. Leal, 2021, Clinical microbiology reviews.

Clinical Significance of Commensal Gram-Positive Rods Routinely Isolated from Patient Samples

P. Gilligan, S. Leal, Melissa C. Jones, 2016, Journal of Clinical Microbiology.

Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens

P. Gilligan, R. L. Kaplan, D. Greer, 1991, Journal of clinical microbiology.

Posttransplantation Disseminated Coccidioidomycosis Acquired from Donor Lungs

P. Gilligan, Melissa B. Miller, R. Hendren, 2004, Journal of Clinical Microbiology.

Microbiome and pediatric atopic dermatitis

P. Gilligan, D. Morrell, C. Burkhart, 2015, The Journal of dermatology.

Mycobacterium chelonae canaliculitis associated with SmartPlug use.

P. Gilligan, W. Fowler, J. Dutton, 2008, Ophthalmic plastic and reconstructive surgery.

Therapeutic challenges posed by bacterial bioterrorism threats.

P. Gilligan, 2002, Current opinion in microbiology.

Localization of Burkholderia cepacia Complex Bacteria in Cystic Fibrosis Lungs and Interactions with Pseudomonas aeruginosa in Hypoxic Mucus

P. Gilligan, S. Randell, R. Arnold, 2014, Infection and Immunity.

Microbiology ofAirwayDisease inPatients withCystic Fibrosist

P. Gilligan, 1991 .

Clostridium difficile in patients with cystic fibrosis.

P. Gilligan, S. Long, C. M. Thompson, 1985, American journal of diseases of children.

Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance.

P. Gilligan, S. Long, M. Teter, 1983, The Journal of infectious diseases.

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

P. Gilligan, K. Hardy, W. Martone, 1985, The Journal of pediatrics.

Will Regulatory and Financial Considerations Dampen Innovation in the Clinical Microbiology Laboratory?

P. Gilligan, M. Miller, Melissa B. Miller, 2016, mBio.

A bacterial cell to cell signal in the lungs of cystic fibrosis patients.

Peter Gilligan, Michael Knowles, P. Gilligan, 2002, FEMS microbiology letters.

Mapping the Road to the Future: Training the Next Generation of Clinical Microbiologists, from Technologist to Laboratory Director.

P. Gilligan, Martha McGee, 2019, Clinics in laboratory medicine.

In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy

R. A. Crawford, J. Morris, P. Gilligan, 1990, Antimicrobial Agents and Chemotherapy.

Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo.

A. Tomasz, P. Gilligan, F. Henderson, 1995, The Journal of infectious diseases.

Optimizing the Laboratory Diagnosis of Clostridium difficile Infection.

P. Gilligan, 2015, Clinics in laboratory medicine.

Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.

P. Gilligan, D. Weber, M. Cohen, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The role of Pseudomonas cepacia in pulmonary disease of cystic fibrosis patients

P. Gilligan, D. Schidlow, 1984 .

In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center

P. Gilligan, F. Henderson, M. J. George, 1991, Antimicrobial Agents and Chemotherapy.

Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination

P. Gilligan, J. Staneck, S. Allen, 1996, Journal of clinical microbiology.

Quantitative Thresholds Enable Accurate Identification of Clostridium difficile Infection by the Luminex xTAG Gastrointestinal Pathogen Panel

P. Gilligan, S. Leal, E. Popowitch, 2018, Journal of Clinical Microbiology.

Is a Two-Step Glutamate Dehyrogenase Antigen-Cytotoxicity Neutralization Assay Algorithm Superior to the Premier Toxin A and B Enzyme Immunoassay for Laboratory Detection of Clostridium difficile?

P. Gilligan, 2008, Journal of Clinical Microbiology.

Is a Two-Step Glutamate Dehyrogenase Antigen-Cytotoxicity Neutralization Assay Algorithm Superior to the Premier Toxin A and B Enzyme Immunoassay for Laboratory Detection of Clostridium difficile?

P. Gilligan, 2008, Journal of Clinical Microbiology.

The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A.

P. Gilligan, D. Willis, W. Kelly, 1993, Archives of Pathology & Laboratory Medicine.

Clostridium difficile peritonitis in a neonate. A case report.

L. R. Mccarthy, P. Gilligan, V. Genta, 1984, Archives of pathology & laboratory medicine.

Evaluation of the latex agglutination test for detection of Clostridium difficile.

P. Gilligan, W. Kelly, K. Wait, 1992, Archives of pathology & laboratory medicine.

Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds.

P. Gilligan, M. Fisher, J. F. Goldsmith, 1985, The Journal of pediatrics.

Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm

Mark O. Buchanan, P. Gilligan, J. Juliano, 2018, Journal of Clinical Microbiology.

Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis

P. Gilligan, J. Lipuma, T. Stull, 1994, The Pediatric infectious disease journal.

Capnocytophaga ochracea Septicemia

L. R. Mccarthy, P. Gilligan, Brenda K. Bissett, 1981, Journal of clinical microbiology.

Cost Savings Realized by Implementation of Routine Microbiological Identification by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry

P. Gilligan, A. Kerr, Anthony Tran, 2015, Journal of Clinical Microbiology.

Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.

P. Gilligan, T. Egan, R. Goldstein, 1994, The New England journal of medicine.

Pertussus Is Rare in Human Immunodeficiency Virus Disease

P. Gilligan, S. Cohn, D. Weber, 1993 .

Impact of Clinical Practice Guidelines on the Clinical Microbiology Laboratory

P. Gilligan, 2004, Journal of Clinical Microbiology.

Point-Counterpoint: Should All Stools Be Screened for Shiga Toxin-Producing Escherichia coli?

P. Gilligan, S. Riddell, D. Kiska, 2011, Journal of Clinical Microbiology.

Blood Culture Contamination A Clinical and Financial Burden

P. Gilligan, 2013, Infection Control & Hospital Epidemiology.

Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus.

P. Gilligan, R. Schwalbe, W. Ritz, 1990, The Journal of infectious diseases.

Endotracheal aspirates: To screen or not to screen, is that even the question?

P. Gilligan, 1999 .

Comparison of Matrix-Assisted Laser Desorption Ionization–Time of Flight (MALDI-TOF) Mass Spectrometry Platforms for the Identification of Gram-Negative Rods from Patients with Cystic Fibrosis

P. Gilligan, K. Alby, M. Miller, 2013, Journal of Clinical Microbiology.

Mycobacterium abscessus Complex Identification with Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry

Julian Parkhill, Peter Gilligan, R. Andres Floto, 2015, Journal of Clinical Microbiology.

Cryptococcus deuterogattii VGIIa Infection Associated with Travel to the Pacific Northwest Outbreak Region in an Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibody-Positive Patient in the United States

J. Heitman, S. Holland, P. Gilligan, 2019, mBio.

Cryptococcus deuterogattii VGIIa infection associated with travel to the Pacific Northwest outbreak region in an anti-GM-CSF autoantibody positive patient in the United States

J. Heitman, S. Holland, P. Gilligan, 2019, bioRxiv.

Identification of Burkholderia and Uncommon Glucose-Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry (MALDI-TOF MS)

P. Gilligan, T. Panagea, D. Pincus, 2016, Journal of Clinical Microbiology.

Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.

David J Weber, P. Gilligan, A. Ivanova, 2016, Clinical therapeutics.

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya.

S. Telford, J. Miller, M. Weinstein, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Report on the consensus document for microbiology and infectious diseases in cystic fibrosis

P. Gilligan, 1996 .

Laboratory diagnosis of Bordetella pertussis infection

P. Gilligan, 1983 .

Correction for Kraft et al., “A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults”

Matthew L. Rubinstein, S. Richter, P. Gilligan, 2019, Clinical Microbiology Reviews.

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya

S. Telford, M. Weinstein, S. Richter, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis

S. Miller, P. Gilligan, A. Kerr, 1996, Journal of clinical microbiology.

Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group

P. Gilligan, P. Della‐Latta, K. Olivier, 1997, Journal of clinical microbiology.

Effect of lindane on nitroreductase and dechlorinase enzyme activity in the gastrointestinal tract.

P. Gilligan, L. Forehand, P. Gilligan, 1990, Toxicology letters.

Aerosolized amiloride for the treatment of lung disease in cystic fibrosis.

M. King, P. Gilligan, J. Henkin, 1990, New England Journal of Medicine.

Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients.

P. Gilligan, F. Lin, C. Esther, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

P. Gilligan, J. Lipuma, R. Aris, 2001, American journal of respiratory and critical care medicine.

Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases

P. Gilligan, D. S. Shapiro, S. Whittier, 1993, Journal of clinical microbiology.

Pertussis is rare in human immunodeficiency virus disease.

P. Gilligan, S. Cohn, D. Weber, 1993, The American review of respiratory disease.

Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms.

Dwight R. Johnson, E. Kaplan, P. Gilligan, 1997, The Journal of infectious diseases.